Delta variant still responsible for 99% of Covid cases globally: WHO

While the world is on high alert due to the new Omicron Covid strain, Delta variant continues to be a major cause of the pandemic contributing to 99 per cent of cases, the WHO said Monday

Coronavirus
Photo: Shutterstock
IANS Washington
3 min read Last Updated : Nov 29 2021 | 2:16 PM IST

While the world is on high alert due to the new Omicron Covid strain, Delta variant continues to be a major cause of the pandemic contributing to 99 per cent of cases, the World Health Organisation (WHO) said on Monday.

Last week, the global health body classified the latest variant B.1.1.529 of SARS-CoV-2 virus, with the name Omicron, as a "Variant of Concern" (VOC), which means it could be more contagious, more virulent or more skilled at evading public health measures, vaccines and therapeutics. First detected from Botswana, in Africa, it has since spread to various countries in Europe, including Belgium, the Netherlands, France and the UK, in Australia and Canada among others.

"We know that at the moment, it's the delta variant that's the major cause of the pandemic around the world. Over 99 per cent of cases around the world are due to the delta variant and more deaths are occurring in the unvaccinated," WHO Chief Scientist Soumya Swaminathan was quoted as saying on CNBC's "Squawk Box Asia" on Monday.

"I think that's our priority while we wait to find out more about (the Omicron) variant," Swaminathan said.

While health experts are concerned about Omicron's transmissibility given its unusual constellation of mutations and profile that differs from previous variants of concern, the WHO said that it is not clear how transmissible the variant is and whether it will increase the severity of disease.

"It is not yet clear whether Omicron is more transmissible (e.g., more easily spread from person to person) compared to other variants, including Delta," the WHO said in a statement.

It is also "not yet clear whether infection with Omicron causes more severe disease compared to infections with other variants, including Delta".

The numbers of infections as well as hospitalisation have risen dramatically in South Africa, where Omicron was discovered. But this may also be due to increasing overall numbers of people becoming infected, rather than a result of specific infection with Omicron.

"There is currently no information to suggest that symptoms associated with Omicron are different from those from other variants. Initial reported infections were among university studies -- younger individuals who tend to have more mild disease -- but understanding the level of severity of the Omicron variant will take days to several weeks," the global health body said, adding "prevention is always key".

Swaminathan said that scientists are conducting experiments and collecting to understand the variant; and also called on countries where the omicron variant has been detected to share their clinical data and genomic sequence data through WHO's platforms for scientists to study.

"What we would like to know is, is this variant more transmissible, even more than delta? We would like to know if there is a different clinical pattern, is it less severe, more severe when it causes disease?" Swaminathan was quoted as saying to CNBC.

"And thirdly, and very importantly, is this variant able to evade immune responses either after natural infection or after vaccines," she added.

However, she stated that currently, it should be assumed that the existing vaccines will provide some protection, if not full protection against the new strain. Thus, "it's really important that everybody out there who's still unvaccinated, or who has received only one dose, must get a full course of vaccination," she said.

--IANS

rvt/dpb

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusDelta variant of coronavirusWorld Health OrganizationCoronavirus TestsCoronavirus Vaccine

First Published: Nov 29 2021 | 2:16 PM IST

Next Story